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Dub3 inhibition suppresses breast cancer invasion
and metastasis by promoting Snail1 degradation
Yadi Wu1,2, Yu Wang1,2, Yiwei Lin2,3, Yajuan Liu2,3, Yifan Wang2,3, Jianhang Jia2,3, Puja Singh4, Young-In Chi4,
Chi Wang2,5, Chenfang Dong6, Wei Li7, Min Tao7, Dana Napier2,8, Qiuying Shi2,8, Jiong Deng9, B. Mark Evers2,10
& Binhua P. Zhou2,3,11
Snail1, a key transcription factor of epithelial–mesenchymal transition (EMT), is subjected to
ubiquitination and degradation, but the mechanism by which Snail1 is stabilized in tumours
remains unclear. We identify Dub3 as a bona fide Snail1 deubiquitinase, which interacts with
and stabilizes Snail1. Dub3 is overexpressed in breast cancer; knockdown of Dub3 resulted in
Snail1 destabilization, suppressed EMT and decreased tumour cell migration, invasion, and
metastasis. These effects are rescued by ectopic Snail1 expression. IL-6 also stabilizes Snail1
by inducing Dub3 expression, the specific inhibitor WP1130 binds to Dub3 and inhibits the
Dub3-mediating Snail1 stabilization in vitro and in vivo. Our study reveals a critical Dub3–Snail1
signalling axis in EMTand metastasis, and provides an effective therapeutic approach against
breast cancer.
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A
pproximately 90% of cancer death are caused by
metastasis1, which is an exceedingly complex process
involving tumour cell motility, intravasation, circulation
in the blood or lymph system, extravasation and growth in
new tissues and organs. The increased motility and invasive
properties of metastatic tumour cells are reminiscent of events
that occur during epithelial–mesenchymal transition (EMT),
which is a distinctive morphogenic process that occurs during
embryonic development, chronic degeneration and fibrosis of
organs, and tumour invasion and metastasis2,3. During EMT,
epithelial cells acquire fibroblast-like properties, exhibit reduced
intercellular adhesion and show increased motility. Several
transcription factors are associated with EMT, including
the Snail1/Slug family4, Twist5, dEF1/ZEB1 and SIP1/ZEB2
(refs 6,7).
Snail1, a zinc-finger containing transcription factor, was
identified in Drosophila as a suppressor of shotgun (an E-cadherin
homologue) transcription, which controls large-scale cell move-
ment during mesoderm formation and neural crest delamina-
tion4. Snail1 expression is tightly regulated during development;
this regulation is often disrupted in metastatic breast cancer.
Overexpression of Snail1 was found in both epithelial and
endothelial cells of invasive breast cancer8. Snail1 expression
correlates with the tumour grade and nodal metastasis for
invasive ductal carcinoma9–11 and predicts a poor outcome in
patients with breast cancer12. Snail1 overexpression also induces
resistance to apoptosis, confers tumour recurrence and generates
breast cancer stem cell (CSC)-like properties13,14. We recently
found that Snail1 induces aerobic glycolysis by repressing
fructose-1,6-biphosphatase (FBP1) expression, and thus
provides metabolic growth advantages to breast cancer15.
Although several signalling pathways, such as EGF, FGF, HGF,
TGFb and Notch, can induce Snail1 transcription under different
cellular contexts16, Snail1 is a labile protein and is under constant
protein ubiquitination and degradation mediated by FBXL14,
b-TRCP1 or FBXO11 (refs 11,17,18). For example, phospho-
rylation of Snail1 by glycogen synthase kinase-3b (GSK-3b)
promotes Snail1 export from the nucleus. In the cytoplasm, Snail1
undergoes a second phosphorylation by GSK-3b, which targets
the protein for b-TRCP1-mediated cytoplasmic degradation.
In addition, PDK1 phosphorylates Snail1 to form a Snail1–
FBXO11 complex in the nucleus17. On the other hand, we
reported that Snail1 stabilization is induced by the inflammatory
cytokine TNFa through the NF-kB pathway to block Snail1
ubiquitination19. However, a comprehensive account of the
mechanisms by which Snail1 escapes ubiquitination and
degradation in breast cancer remains unknown.
Ubiquitination is a reversible process and ubiquitin
moieties are removed from polypeptides by Deubiquitinases
(DUBs). DUBs are classified into ubiquitin C-terminal hydrolase
(UCH), ubiquitin-specific processing proteases (USP), Jab1/Pad1/
MPN-domain containing metallo-enzymes (JAMM), Otu
domain ubiquitin-aldehyde binding proteins (OTU) and
Ataxin-3/Josephin-domain containing proteins (Ataxin-3/Jose-
phin). Growing evidence shows that DUBs are essential for the
regulation of many cellular functions including transcription,
DNA repair and cell cycle progression20. Dub3 belongs to
the USP group, and is an immediate early gene that belongs
to a subfamily of cytokine-inducible DUBs20. Specifically, Dub3 is
rapidly induced by IL-4 and IL-6 (refs 21,22). Cdc25A is a known
substrate of Dub3 that promotes oncogenic transformation23.
In agreement with this report, high Dub3 expression in mouse
embryonic stem cells couples the G1/S checkpoint to pluripotency
through regulation of Cdc25A (ref. 24), and depletion of Dub3
from breast cancer cells reduces proliferative potential in vivo.
In addition to the role in breast cancer, Dub3 expression
correlates with tumour progression and poor prognosis in
human epithelial ovarian cancer25. However, these observations
do not specifically explain the role of Dub3 in mediating
tumour cell invasion and metastasis.
In the current study we utilize unbiased approaches to
identify the specific DUB responsible for Snail1 stabilization,
and identify Dub3 as a bona fide DUB of Snail1. The
Dub3–Snail1 signalling axis forms a ‘sensor and effector’ circuitry
by overlaying inflammatory stimulation to EMT and metastasis.
Results
Dub3 is a deubiquitinase of Snail1. To understand the regula-
tion of Snail1, we purified the Snail1 complexes from nuclear
extracts of 20 l HeLa S3 cells expressing Flag-Snail1 (ref. 26).
The immunocomplex was separated on SDS–PAGE and
subjected to top-down mass spectrometry analysis. We deter-
mined that several histone methyltransferases/demethylases,
such as LSD1 (ref. 26), Suv39H1 (ref. 27) and G9a (ref. 28) as
well as Dub3, were associated with Snail1 (Supplementary
Fig. 1a). In a parallel experiment, we performed a small inter-
fering RNA (siRNA) library screening, which consisted of
four non-overlapping siRNA targeting the 99 known or putative
DUBs. This initial screen identified 11 genes that may directly
or indirectly control Snail1 stability (Supplementary Fig. 1b).
When these DUBs were co-expressed with Snail1 in HEK293
cells, we found that USP12, Dub3 and USP28 significantly
increased Snail1 levels, similar to results obtained when cells
were treated with the proteasome inhibitor MG132
(Supplementary Fig. 1b). However, only Dub3 interacted with
Snail1 in the co-immunoprecipitation (IP) assay (Supplementary
Fig. 1c). These two independent and unbiased analyses point
to the critical role of Dub3 in the regulation of Snail1.
To further investigate the relationship of these two proteins,
we co-expressed Snail1 with Dub3 in HEK293 cells. Expression
of wild-type (WT) Dub3 stabilized Snail1. A Dub3 mutant,
in which the catalytic cysteine had been replaced with serine
(C89S, CS), showed no such effect, indicating that the enzymatic
activity of Dub3 is required for Snail1 stabilization (Fig. 1a).
A steady-state level of Snail1 was enhanced by increasing
Dub3 expression in a dose-dependent manner (Fig. 1b).
When Dub3 was co-expressed with GFP-Snail1 in HEK293 cells,
we found that Dub3 stabilized and co-localized with GFP-Snail1
in nuclei (Fig. 1c). Although we did not find any correlation
between Dub3 and Snail1 mRNA levels, expressions of Dub3 and
Snail1 in multiple cancer cell lines, ranging from colon, prostate
and breast tumours, were highly correlated (Fig. 1d). Dub3 was
highly expressed in basal-like breast cancer (BLBC) cells that
contain high levels of Snail1. In addition, Dub3 expression
correlated with Snail1 in colon and prostate cancer cell
lines, suggesting that this Dub3–Snail1 correlation is not tissue-
specific. Dub3 expression also correlated with Snail1 levels in
12 cases of fresh breast tumours (Fig. 1e). These data suggest
that Dub3 controls the level of Snail1 through deubiquitination
to prevent degradation. Consistent with this idea, knockdown
of endogenous Dub3 resulted in a rapid loss of endogenous
Snail1 protein, but had no effect on mRNA levels, in
MDA-MB231 and MDA-MB157 cells (Fig. 1f). The down-
regulation of Snail1 in Dub3-knockown MDA-MB157 cells
was restored by MG132 treatment (Fig. 1g), indicating that
Dub3-knockdown facilitates the ubiquitination and degradation
of Snail1.
Dub3 is evolutionarily conserved from Drosophila
to humans29. Strikingly, knocked-out Dub3 expression using
UAS-RNAi lines that target Dub3 in Drosophila, show
no invagination/gastrulation, which require both EMT and stem
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Figure 1 | Dub3 stabilizes Snail1. (a) Flag-Snail1 was co-expressed with HA-tagged Dub3 (either wild-type, WT, or catalytic inactive C89S mutant, CS) in
HEK293 cells or cells were treated with MG132 for 6h. Expression of Snail1 and Dub3 were assessed by western blot. (b) Flag-Snail1 was co-expressed with
increasing amounts of HA-Dub3 in HEK293 cells. Lysates were subjected to analysis by western blot. (c) GFP-Snail1 was co-expressed with HA-Dub3 in
HEK293 cells. After fixation, the cellular location of Snail1 (green) and Dub3 (red) was examined by immunofluorescent (IF) staining using anti-HA antibody
and visualized by fluorescence microscopy (nuclei were stained with Dapi; blue). Arrowhead identifies a cell expressing only GFP-Snail1 but not Dub3. Scale
bars, 25mm. (d) The protein expression of Dub3 and Snail1 in various cancer cell lines was analysed by western blot. (e) Expression of Dub3 and Snail1 from 12
human breast tumours (fresh frozen) was analysed by western blot. (f) The protein expression of Dub3 and Snail1 from MDA-MB157 and MDA-MB231 cells
stably transfected with control or two individual Dub3 shRNAs was analysed by western blot and the mRNA was detected by real-time PCR (mean±s.e.m. in
three separate experiments). (g) The protein expression of Dub3 and Snail1 from MDA-MB157 cells stably transfected with control or two individual Dub3
shRNAs and treated with or without 10mM MG132 for 6 h was analysed by western blot. (h) Gastrulation and Snail1 expression were detected in Drosophila
embryos and the mRNA was detected by real-time PCR using stage 11 cells (mean±s.e.m. in three separate experiments).
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cell renewal (up panel, Fig. 1h). This observation was very
similar to that seen with a mutant Snail1 in Drosophila embryos,
in which Snail1 is absolutely required for the dissociation and
invagination of cells from epiblast30. Consistent with this
observation, we noticed a drastic reduction of Snail1 in stage
11 cells. In addition, expression of several genes that are known
to be repressed by Snail1 in this event, such as Rho, Sim and
T3, were restored in embryos isolated from these RNAi lines
(bottom panel, Fig. 1h). Together, these data indicated that
Dub3 is specific for the control of Snail1 in vivo.
Dub3 interacts with Snail1. To further investigate the interaction
of Dub3 with Snail1, we co-expressed Flag-Dub3 and HA-Snail1
in HEK293 cells and performed a co-IP experiment. After IP of
Snail1, we detected an associated Dub3, and vice versa (Fig. 2a).
IP of endogenous Snail1 and Dub3 from MDA-MB157 and
MDA-MB231 cells also demonstrated the presence of endogen-
ous Dub3 and Snail1, respectively (Fig. 2b). To identify the region
in Snail1 that associates with Dub3, we generated two deletion
mutants of Snail1 (refs 28,31): the N-terminal Snail1 (amino acids
1–153), which contains the SNAG domain of Snail1; and the
C-terminal Snail1 (amino acids 153–264), which includes the
conserved zinc finger motif (Fig. 2c). When these two deletion
mutants of Snail1 were co-expressed with Dub3 in HEK293 cells,
we found that the N-terminal region of Snail1 was responsible for
its interaction with Dub3 (Fig. 2c). In addition, when GST-Dub3
was incubated with full-length or deletion mutants of Snail1,
only the full-length and N-terminal domain of Snail1 were pulled
down by GST-Dub3 (Fig. 2d).
Dub3 contains two functional domains; the N-terminal
catalytic (UCH) domain and two hyaluronan binding motifs
at its C terminus. To identify the region of Dub3 responsible
for the interaction with Snail1, we generated a Myc-tagged
full-length, N-terminal deletion, and C-terminal deletion of
Dub3 (Fig. 2e) and co-expressed them with Snail1 in HEK293
cells. We found that the N-terminal catalytic domain retained the
ability to interact with Snail1. However, when the C-terminal
mutant was utilized, Dub3 was unable to interact with Snail1.
When GST-Snail1 was pulled down, we found the presence
of full-length and N-terminal Dub3 (Fig. 2f). Consistent with
this, Dub3 only stabilized the N-terminal but not the C-terminal
fragments of Snail1 (Fig. 2g). The interaction between Dub3 and
Snail1 was further confirmed by immunofluorescence (IF)
analysis showing that endogenous Dub3 co-localized with Snail1
in the nucleus of MDA-MB231 cells (Fig. 2h). Taken together,
our results indicate that Dub3 interacts with Snail1 and that
this interaction is mediated through the N-terminal regions of
Dub3 and N-terminal region of Snail1.
Dub3 stabilizes Snail1 through deubiquitination. The interac-
tion of Dub3 with Snail1 suggests that Dub3 regulates the
protein stability of Snail1. To test this idea, we co-expressed
Snail1 with Dub3 or vector control in HEK293 cells and
examined Snail1 degradation. After treatment with cycloheximide
to block newly protein synthesis, Snail1 degraded rapidly in
cells transfected with a control vector (Fig. 3a). However, Snail1
levels were stabilized in the presence of Dub3 and this effect
continued for up 4 h in the presence of cycloheximide. To test
whether endogenous Snail1 is also subjected to similar regulation
by Dub3, we knocked down endogenous Dub3 in MDA-MB231
cells, and found that endogenous Snail1 became unstable
and degraded rapidly (Fig. 3b). To extend these findings
and determine whether this Dub3 effect is mediated through
a de-ubiquitination of Snail1, we co-expressed Flag-Snail1
with either WT- or CS-Dub3 in HEK293 cells. After
immunoprecipitating Snail1 from cells treated with MG132, we
found that Snail1 was heavily ubiquitinated (lane 1, Fig. 3c).
However, co-expression of WT-Dub3 almost completely
abolished Snail1 ubiquitination while the CS-Dub3 did not have
this effect (lanes 2 versus 3, Fig. 3c). Conversely, Snail1 ubiqui-
tination significantly increased in Dub3-knockdown
MDA-MB157 and MDA-MB231 cells after MG132 treatment
(Fig. 3d). In an in vitro deubiquitination assay as described by
Dupont et al.32, we incubated poly-ubiquitinated Snail1 with
purified WT-Dub3 or CS-Dub3. We found that WT-Dub3,
but not CS-Dub3, specifically removed Snail1 ubiquitin moieties
in vitro (Fig. 3e), indicating that Dub3 stabilizes Snail1 by
removing its ubiquitination directly.
Previous studies showed that b-TRCP1 and FBXL14
are specific E3 ligases mediating the ubiquitination and degrada-
tion of Snail1 (refs 11,18,33). We investigated whether
Dub3 stabilized Snail1 by impeding the activity of b-TRCP1
and FBXL14. Consistent with prior results, expression of
b-TRCP1 and FBXL14 increased Snail1 protein degradation
(lanes 4 and 7 versus lane 1, Fig. 3f). Expression of the WT-Dub3,
but not CS-Dub3, blocked Snail1 degradation mediated by these
two ligases. Conversely, knockdown b-TRCP1 or FBXL14
increased Snail1 stability (lanes 2 and 3, Fig. 3g). However,
knockdown of Dub3 blocked the Snail1 stabilization effect
mediated by the knockdown of either b-TRCP1 or FBXL14
(lanes 4 and 5, Fig. 3g), indicating that Dub3 is a critical factor
controlling Snail1 stability. In agreement with this observation,
expression of b-TRCP1 and FBXL14 increased Snail1 polyubi-
quitination (Fig. 3h), which was attenuated by expression of
WT-Dub3 (lanes 3 versus 2, lanes 6 versus 5, Fig. 3h). Knock-
down of b-TRCP1 or FBXL14 reduced Snail1 polyubiquitination,
which was hampered by simultaneous knockdown Dub3
(Supplementary Fig. 2a). Both b-TRCP1 and FBXL14 share the
same lysine pattern and target Snail1 degradation through
ubiquitin modification of lysine 98, 137 and 146 (ref. 18).
Consistent with previous reports, the Snail1 triple mutant (K3R)
is more stable than WT-Snail1 (Supplementary Fig. 2b).
However, ectopic expression of Dub3 still increased
K3R accumulation, indicating that other lysines could be involved
in Snail1 stability. Together, these data demonstrated that
Dub3 counteracts b-TRCP1- and FBXL14-mediated Snail1
ubiquitination through deubiquitination.
Dub3 expression induces EMT. To study the functional effects of
Dub3, we expressed Dub3 in two luminal breast tumour cell lines,
MCF7 and T47D, which contain little endogenous Dub3 and
Snail1 (Fig. 4a). Dub3 expression induced Snail1 stabilization
as well as downregulation of E-cadherin and oestrogen receptor
alpha (ERa) in these cells (Fig. 4a,b). Consistently,
Dub3 expression induced a morphologic change indicative of
EMT (Fig. 4b), including downregulation of epithelial markers
(E-cadherin, Claudin-7 and Occludin) and the upregulation
of mesenchymal molecules (N-cadherin and Vimentin)
(Fig. 4c, Supplementary Fig. 3a). In addition, Dub3 expression
converted these luminal cells into a basal-like phenotype; these
cells lost luminal markers, such as ERa, FOXA1, CK18 and
AGR2, and gained expression of basal molecules such as
CK5, CD44 and EGFR (Fig. 4d, Supplementary Fig. 3a). We
then tested the migration and invasiveness of these cells.
Dub3 expression markedly increased the cell migration and
invasive capacity (Fig. 4e,f, Supplementary Fig. 3b,c).
The catalytic activity of Dub3 is required for these functions,
because CS-Dub3 could not induce Snail1 upregulation, or
the morphological changes associated with EMT, or increased cell
migration and invasion in these cells (Fig. 4a–f, Supplementary
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Fig. 3a–c). In addition, these functional activities promoted
by Dub3 required Snail1 upregulation, because knockdown of
Snail1 greatly inhibited these changes (Fig. 4a–f, Supplementary
Fig. 3a–c). Together, these data indicate that Dub3 can
induce EMT (luminal to basal-like phenotype conversion) by
stabilizing Snail1 in breast cancer cells.
Knockdown of Dub3 suppresses Snail1’s function. To further
assess the function of Dub3 in breast cancer, we established
stable clones with Dub3 knockdown in MDA-MB231 and
MDA-MB157 cells. We achieved 80–90% knockdown efficiency
of endogenous Dub3 using two independent shRNAs (Fig. 5a).
For both clones, Dub3-knockdown increased E-cadherin and
Claudin-7 levels, downregulated expression of Vimentin and
N-Cadherin, with concomitant changes of other EMT markers
(Fig. 5a, Supplementary Fig. 4a). IF analysis also suggested
a downregulation of E-cadherin and upregulation of Vimentin
and N-cadherin (Fig. 5b). Dub3 knockdown greatly inhibited
the migration and invasive capabilities of these cells
(Fig. 5c,d, Supplementary Fig. 4b,c). Individual cell tracking
also revealed Dub3 knockdown reduced the velocity and direc-
tionality of cell migration, and strongly inhibited the net distance
of cell migration in MDA-MB231 and MDA-MB157 cells
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(Fig. 5e, Supplementary Fig. 4d). Importantly, Snail1-rescued
expression partially inhibited E-cadherin and claudin-7
upregulation and increased Vimentin and N-cadherin expression
in Dub3-knockdown MDA-MB231 and MDA-MB157 cells
(Fig. 5a,b). Functionally, Snail1-rescued expression also restored
migration and invasion in these Dub3-knockdown cell lines
(Fig. 5c–e, Supplementary Fig. 4b–d).
MDA-MB231 and MDA-MB157 cells appear with stellate
projections in 3D culture. Cells with Dub3 knockdown exhibited
a marked change in morphology, with rounded/polygonal
shape (Supplementary Fig. 4e). To extend assessment of
the critical role of Dub3 in regulating CSC-like properties in
human breast cancer, we examined tumorsphere formation
in Dub3-knockdown clones. We found that Dub3 knockdown
greatly reduced the number and size of primary and secondary
tumorspheres in MDA-MB231 and MDA-MB157 cells
(Fig. 5f, Supplementary Fig. 5a). This function of Dub3 is likely
mediated through the regulation of Snail1, as Snail1 rescued
expression (expressing Snail1-IRES-GFP) greatly restored
the number and size of tumorspheres in these two cell lines. As
human breast CSCs are enriched in a CD44high/CD24low
population14,34–38, we measured this population in
MDA-MB157 and MDA-MB231 cells with Dub3 knockdown
using fluorescence-activated cell sorting (FACS). We found that
Dub3 knockdown reduced the CD44high/CD24low population in
both cell lines (Fig. 5g, Supplementary Fig. 5b). To corroborate
these findings, we also used a second set of breast CSC markers
(CD49fhigh/CD24low)39–42. Similar to the results presented above,
Dub3 knockdown reduced the population of CD49fhigh/CD24low
cells in MDA-MB231 and MDA-MB157 cells (lower panel
in Fig. 5g, Supplementary Fig. 5c). Again, the reduction of
a CSC population in Dub3-knockdown clones appears to be
mediated by the downregulation of Snail1, as rescued Snail1
expression in Dub3-knockdown clones largely recovered the
CSC phenotype. Taken together, these results clearly support
our assessment that Dub3 is the crucial factor controlling
Snail1 stability, EMT, migration and invasion, as well as
CSC characteristics.
Knockdown of Dub3 blocks breast cancer metastasis. To
directly assess whether Dub3 promotes metastasis in vivo, we
intravenously injected Dub3-knockdown MDA-MB231 cells into
female SCID mice and subjected these mice to bioluminescent
imaging (BLI). Dub3-knockdown cells exhibited a reduced
number of lung nodules at early time points (Fig. 6a,b), implying
that Dub3 is critical for the extravasation and/or colonization
of breast tumour cells in lung. At 35 days post-injection, all
control mice were moribund due to massive lung metastases with
an average of 150 visible metastatic nodules per mouse (Fig. 6c,d).
In contrast, mice injected with Dub3-knockdown cells were viable
and free of detectable metastases. Histologic analyses supported
the macroscopic observations and disclosed a high number
of metastatic lesions produced by control cells whereas
Dub3-knockdown cells lacked metastatic colonies (Fig. 6c,d).
Consistent with the function of Snail1 in vitro, expression of
exogenous Snail1 in Dub3-knockdown cells largely rescued the
formation of lung metastases (Fig. 6a,d).
Snail1 is a key transcription factor of EMT4,43. To rule out
the possibility of cellular adaptation effect associated with stable
gene downregulation and to examine the temporal regulation of
Snail1 in vivo, we generated a doxycycline (DOX)-inducible
expression of Dub3 shRNA or control shRNA (TRIPZ lentiviral
inducible shRNAmir system from Thermo Fisher Scientific)
in MDA-MB231 cells. Treatment with DOX for 6 days achieved
almost complete Dub3-knockdown and resulted in a remarkable
downregulation of Snail1 (Fig. 6e). In an experimental metastasis
model, we intravenously injected these cells into female
SCID mice (left panel, Fig. 6f). Mice received DOX or no
DOX in the drinking water 24 h after tumour cell inoculation.
Dub3 knockdown after DOX treatment significantly decreased
lung metastasis and lung weight, but these parameters showed no
difference in control mice with or without DOX treatment
(middle and right panels, Fig. 6f).
To further examine the therapeutic efficacy of systemic
inhibition of Dub3 in preventing tumour recurrence and
metastasis, we performed a spontaneous metastasis model
analysis, in which control and DOX-inducible Dub3 shRNA
MDA-MB231 cells were implanted into mammary fat pads
of 6-week-old female SCID mice. When tumours reached
a volume of 1 cm3, the tumours was surgically removed. Mice
then received DOX or no DOX in drinking water (left panel,
Fig. 6g). Strikingly, the recurrent tumour was significantly
inhibited in mice with the Dub3 shRNA expression
(middle panel, Fig. 6g). In parallel, depletion of Dub3 also
dampened spontaneous lung metastasis (right panel, Fig. 6g).
Collectively, these data indicate that Dub3 facilitates breast cancer
metastasis through, in large part, Snail1 stabilization.
Dub3 is critical for IL-6-induced Snail1 stabilization. We
showed previously that IL-6 and TNFa can stabilize Snail1 by
Figure 3 | Dub3 deubiquitinates Snail1 and antagonizes the function of Snail1’s E3 ligase. (a) Flag-Snail1 was co-expressed with vector or Myc-Dub3 in
HEK293 cells. After treatment with cycloheximide (CHX) for the indicated time intervals, expression of Snail1 and Dub3 was analysed by western blot
(top panel) using Flag and Myc antibodies, respectively. The intensity of Snail1 expression for each time point was quantified by densitometry and plotted
(bottom panel). Experiment was repeated three times and a representative experiment is presented (mean±s.e.m. in three separate experiments).
(b) MDA-MB231 cells were transfected with control or Dub3 siRNA. After treatment with CHX as indicated above, expression of endogenous Snail1 and
Dub3 was analysed by western blot (top panel); the intensity of Snail1 expression for each time point was quantified by densitometry and plotted (bottom
panel) (mean±s.e.m. in three separate experiments). Experiment was repeated three times and a representative experiment is presented. (c) Flag-Snail1
and HA-ubiquitin were co-expressed with WTor CS mutant Dub3 in HEK293 cells. After treatment with 10mM MG132 for 6 hr, Snail1 was subjected to IP
and the poly-ubiquitination of Snail1 assessed by western blot using HA antibody. IP Snail1 was blotted using Flag antibody. Input protein levels of Snail1 and
Dub3 were examined using Flag and Myc antibodies, respectively. (d) MDA-MB231 and MDA-MB157 cells stably transfected with control, or Dub3 shRNA
were treated with MG132 for 6 hr. Extracts were subjected to IP with Snail1 antibody and the poly-ubiquitination of Snail1 assessed by western blot using
ubiquitin antibody. Input of Snail1 and Dub3 were analysed by western blot. (e) Ubiquitinated Snail1 was purified from MG132-treated HEK293 cells
expressing Flag-Snail1, and then incubated with purified Myc-tagged WT-Dub3 or CS-Dub3 in a deubiquitination assay as described in Experimental
Procedures. The poly-ubiquitinated state of Snail1 was assessed by western blot using HA antibody. The immuno-purified Snail1 and Dub3 used in this
assay were analysed using Flag and Myc antibodies, respectively. (f) Flag-Snail1 was co-expressed with the indicated expression plasmids, and the
expression of Snail1, Dub3, FBXL14, and b-TRCP1 were analysed by western blot. (g) MDA-MB231 cells were transfected with indicated siRNA and cell
lysates were analysed by western blot. (h) Flag-Snail1 and HA-ubiquitin were co-expressed with indicated expression plasmids in HEK293 cells. After
treatment with 10mM MG132 for 6 h, Snail1 was obtained by IP and the poly-ubiquitination of Snail1 assessed detected by western blot using HA antibody.
IP Snail1 was blotted using Flag antibody. Input protein levels for Dub3, FBXL14 and b-TRCP1 were assessed by western blot.
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inhibiting the ubiquitination of Snail1, leading to EMT19.
Interestingly, Dub3 was initially identified as an early response
gene after stimulation by IL-6 and other cytokines21,22. These
observations prompted us to investigate whether IL-6 induces
Snail1 stabilization through Dub3 expression. We treated
MDA-MB231 and MDA-MB157 cells with IL-6 (50 ngml 1)
for different time intervals. Consistent with previous findings22,
Dub3 was rapidly induced in these two cell lines after 1 h of
IL-6 stimulation (Fig. 7a). Snail1 was also robustly increased after
1 h of IL-6 stimulation and levels reached a maximum at 2 h.
However, Snail1 mRNA levels showed no significant increase by
4 h of IL-6 treatment in these two cell lines (Supplementary
Fig. 6a). In contrast, Dub3 knockdown in MDA-MB231 and
MDA-MB157 cells not only reduced the endogenous level of
Snail1 but also blocked IL-6-induced Snail1 stabilization (Fig. 7b).
The enzymatic activity of Dub3 is dependent on the ubiquitin
carboxyl-terminal hydrolase (UCH) domain, which shares
B50% sequence similarity (including strictly conserved catalytic
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Figure 4 | Overexpression of Dub3 induces EMT. (a) WT- or CS-Dub3 was expressed in MCF7 and T47D cells. A rescue experiment with knockdown
of Snail1 expression in WT-Dub3 expressing cells was also performed. The level of Snail1, Dub3, E-cadherin and ERa was analysed by western blot.
(b) WT- or CS-Dub3 was expressed in MCF7 cells. A rescue experiment with knockdown of Snail1 expression in WT-Dub3 expressing cells was also
performed. Morphologic changes indicative of EMT are shown in the phase contrast images; expression of E-cadherin, ERa and Dub3 was assessed by
IF staining. Nuclei were visualized with DAPI (blue). Scale bars, 20mm. (c,d) WT- or CS-Dub3 was expressed in MCF7 cells. A rescue experiment with
knockdown of Snail1 expression in WT-Dub3 expressing cells was also performed. The mRNA levels of epithelial, mesenchymal (c), luminal, and basal
(d) markers were quantitated by real-time PCR. Data are shown as mean±s.d. of two separate experiments in triplicates. (e) Boyden chamber migration
assay of modified MCF7 and T47D cells, as described in a. Data are presented as mean±s.e.m. (f) Boyden chamber invasion assay of modified MCF7 and
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residues) with the UCH domain of USP2 (ref. 44), for which
a structure has recently been reported (PDB access code
2HD5; please see ‘Methods’ for detail)45. We performed
a docking analysis with several known DUB inhibitors and
found that WP1130 could bind to the catalytic entry site of the
UCH domain (left and middle panels, Fig. 7c)46–48. The physical
interaction between recombinant Dub3 protein and WP1130
was further confirmed by an in vitro thermal shift binding
assay49. As shown in Fig. 7c (right panel), WP1130 binding
to Dub3 significantly shifted the melting temperature (Tm) of
M
ig
ra
tio
n 
(%
)
0
20
40
60
80
100
120
MDA231 MDA157
In
va
si
on
 (%
)
MDA231 MDA157
–250
–150
–50
50
150
–400 100
shDub3-1 shDub3-1+SN
M
D
A-
M
B2
31
M
D
A-
M
B1
57
–250
–150
–50
50
150
–400 100
–250
–150
–50
50
150
–400 100
–250
–150
–50
50
150
–400 100
–250
–150
–50
50
150
–400 100
–250
–150
–50
50
150
–400 100
shNTC
0
20
40
60
80
100
120
a b
c d f
e
shNTC
shDub3–1
shDub3–2
shDub3+SN
shNTC shDub3–1 shDub3–2 shDub3–1+SN
E-
ca
dh
er
in
Vi
m
en
tin
N
-c
ad
he
rin
shNTC
shDub3–1
shDub3–2
shDub3+SN
0
20
40
60
80
100
120
0
10
20
30
40
50
60
M
am
m
os
ph
er
e 
(#)
MDA231 MDA157
Primary
MDA231 MDA157
Secondary
0
20
40
60
80
100
120
CS
C 
po
pu
la
tio
n 
(%
) 
MDA231 MDA157
shNTC
shDub3-1
shDub3-2
shDub3+SN
CS
C 
po
pu
la
tio
n 
(%
) 
0
20
40
60
80
100
120
CD44+/CD24–
CD49f+/CD24–
MDA231 MDA157
g
N-cad
E-cad
MDA-MB157MDA-MB231
Claudin-7
Vimentin
Actin
Dub3
Snail
shNTC + – – – + – – –
shDub3-1 – + – + – + – +
shDub3-2 + – – – + –
Snail
– –
– – – + – – – +
22
kDa
54
100
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in a. Data are the percentage of vector control values (mean±s.e.m. in three separate experiments in duplicates). (e) Cell trajectories of randomly selected
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Dub3 while the furan compound (negative control) had no
effect under the same conditions. Negative Tm shifts (DTm) can
be attributed to the compound destabilizing the protein or to
the compound aggregating and causing early destabilization50.
These types of negative shifts were observed for the compounds
which contain heavy metal atoms, such as bromine (Br) in
WP1130, and generate energetically unfavourable strains
when interacting with the proteins51,52. In addition, the
direct binding between Dub3-UCH and WP1130 was
demonstrated by the shifts during a native gel analysis in
which similar dose-dependency and potential protein
destabilization was observed (Supplementary Fig. 6b). These
data clearly indicate that WP1130 physically interacts with
Dub3 and can potentially alter its enzymatic activity. We thus
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treated MDA-MB231 cells with WP1130 and PR619,
a non-selective inhibitor of the deubiquitinating enzymes53.
Treatment of 0.5 mM WP1130 dramatically inhibited the intrinsic
and IL-6-induced Snail1 stabilization while PR619 was less
effective (Supplementary Fig. 6c). These results provide proof-of-
concept that a Dub3 inhibitor will suppress the function of Snail1
by promoting its degradation; the findings also provide insight
into an effective treatment modality for patients with BLBC.
To further assess whether WP1130 treatment can inhibit
Snail1 function, we first assessed the cytotoxicity of this
compound in normal human breast epithelial (MCF10A) and
in tumour (MDA-MB231) cell lines. Treatment with 1mM
WP1130 for up to 48 h, did not elicit any cytotoxicity in these
cells (Supplementary Fig. 6d). We then treated the cells with
0.5 mM WP1130 and performed functional assays. We found
that WP130 not only reduced tumour cell migration and invasion
but also inhibited tumour mammosphere formation (Fig. 7d–f,
Supplementary Fig. 7a–c). The suppressive effects of WP1130
are mainly mediated through Dub3 inhibition, because
Dub3 knockdown greatly reduced the suppressive effects
mediated by WP1130.
In vivo studies were performed by injecting MDA-MB231 cells
into the mammary fat pads of NOD-SCID mice. When tumours
were B100mm3, mice were divided into two groups to receive
treatments of WP1130 or solvent control for two weeks. We
found that WP1130 treatments significantly inhibited tumour
growth (Fig. 7g–i). Taken together, these data indicate that the
Dub3–Snail1 axis is the critical ‘sensor-executor module’
controlling EMT in response to microenvironmental signals.
Dub3 and Snail1 are coordinately overexpressed in tumours.
To further examine the Dub3–Snail1 relationship in human
breast cancer, we performed immunohistochemical (IHC)
analysis to examine Dub3 and Snail1 expression in a breast
TMA generated by the Bio-specimen Repository in our Cancer
Center at the University of Kentucky College of Medicine. The
TMA contains 334 cases of breast tumour specimens, including
110 luminal, 59 HER2-overexpressing and 165 triple-negative
breast cancer (TNBC) (Tables 1–3). Consistent with our
observations in tumour cell lines, the intensity and distribution of
Dub3 positively correlated with Snail1 in TNBC (Tables 1–3,
Fig. 8a). We also found that Dub3 was upregulated in invasive
tumour tissue compared with normal breast tissue from two
gene expression datasets in Oncomine (Supplementary Fig. 8).
Because Snail1 expression predicts decreased relapse-free
survival in women with breast cancer54, we reasoned that
women with primary breast cancers expressing high level of
Dub3 relapsed at a faster rate than women whose breast cancers
express low level of Dub3 in a pattern similar to that of Snail1.
Therefore, we analysed two microarray expression datasets
derived from primary human breast cancers in which both
Dub3 expression level and clinical outcome were available.
Intriguingly, individuals with high Dub3 expression had
a significantly higher probability of developing distant
metastasis and a reduced interval of disease-free survival
(Fig. 8b). These results suggest that Dub3 expression may
represent an important prognostic indicator for breast cancer in
the clinical setting.
Discussion
Snail1 is a crucial transcription factor that plays an essential role
in EMT, metastasis, CSC-like properties, metabolism and tumour
recurrence. In this study, we found that Dub3 is a bona fide
DUB for Snail1. The function of Dub3 is likely conserved from
Drosophila to mammals, and knockdown of Dub3 increases,
whereas Dub3 expression decreases, the ubiquitination and
degradation of Snail1. The loss of Dub3 can be rescued by
expressing exogenous Snail1. Most critically, a tight correlation
between Dub3 and Snail1 on multiple cancer cell lines and
human breast tumour specimens confirms their potential
regulation. Our study provides several new insights into the
involvement of ubiquitination in breast cancer metastasis. First,
our study suggests that the Dub3–Snail1 signalling axis represents
an important ‘sensor-executor’ module in breast cancer. It has
Table 1 | Expression of Snail1 in different subtypes of breast
tumour specimens.
Snail1 Total
Negative Low High
Non-TNBC
*Luminal (ERþ ) 42 38 30 110 169
wHER2þ 15 26 18 59
zTNBC (ER , PR , HER2 ) 21 33 111 165
Total 78 97 159 334
*P¼0.210, R¼ 0.097.
wP¼0.210, R¼0.097.
zP¼0.010, R¼0.488.
Table 2 | Expression of Dub3 in different subtypes of breast
tumour specimens.
Dub3 Total
Negative Low High
Non-TNBC
*Luminal (ERþ ) 36 45 29 110 169
wHER2þ 14 23 22 59
zTNBC (ER , PR , HER2 ) 32 31 102 165
Total 82 99 153 334
*P¼0.112, R¼ 0.123.
wP¼0.112, R¼0.123.
zP¼0.010, R¼0.379.
Table 3 | Co-expression of Dub3 and Snail1 in different
subtypes of breast cancer specimens.
Dub3 Snail1 Total
Negative Low High
Non-TNBC
*Luminal (ERþ )
Negative 17 12 7 36 110 169
Low 16 13 16 45
High 9 13 7 29
wHER2þ
Negative 3 8 3 14 59
Low 6 12 5 23
High 6 6 10 22
zTNBC (ER , PR , HER2 )
Negative 17 8 7 32 165
Low 2 15 14 31
High 2 10 90 102
Total 78 97 159 334
*P¼0.265, R¼0.107.
wP¼0.424, R¼0.106.
zP¼0.001, R¼0.643.
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been noted that the migration and invasive capabilities of tumour
cells at the invasive front are initiated and propelled by
an inflammatory microenvironment through the induction of
EMT. IL-6, a major cytokine present in the tumour microenvir-
onment, can induce EMT and promote metastasis through the
STAT3 signalling pathway in breast cancer, head and
neck cancer and pancreatic cancer55. Elevated IL-6 level
predicts tumour recurrence, poor response to chemotherapy,
poor survival and tumour metastasis56. IL-6 is also identified
as a major cytokine secreted by BLBC cells and is essential for
the CSC-like characteristic of BLBC57. Therefore, it is likely
that BLBC cells and infiltrated TAMs secrete IL-6 and provide
a
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Figure 8 | Expression of Dub3 and Snail1 are positively correlated in breast cancer patients. (a) The 334 surgical specimens of breast cancer were
immunostained using antibodies against Dub3, Snail1, and the control serum (data not shown). Images with consecutive IHC staining of both Dub3 and
Snail1 in six cases of breast tumours (top panel: three cases of negative staining; bottom panel: three cases of positive) are shown (Scale bars, 50 mm).
Statistical analysis is shown Tables 1–3. (b) Kaplan–Meier plots of distant metastasis-free survival of patients, stratified by expression of Dub3. Data
obtained from the TCGA and Finak database. P-values represent log-rank testing of the difference in cumulative survival. (c) A proposed model to illustrate
Dub3 induces Snail1 stabilization through a deubiquitination event. IL-6 induces the expression of Dub3, which antagonizes the function Snail1’s ubiquitin E3
ligase (such as FBXL14 and b-TRCP1), leading to Snail1 stabilization and the acquisition of EMT and metastasis.
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autocrine and paracrine feed-forward mechanisms, respectively,
to sustain EMT and maintain CSC-like traits. Intriguingly,
BLBC cells contain high levels of Dub3 and Snail1 and possess
invasiveness and CSC-like characteristics. In contrary, the
ERa-positive luminal subtype breast tumour cells (such as
MCF7 and T47D), do not express IL-6 (ref. 55) and contain
little Snail1. Interestingly, Dub3 is an early response gene of
IL-6, and our study indicates that Dub3 is a critical
deubiquitinase of Snail1. Therefore, Dub3 is one of the ‘long-
sought’ missing molecule that senses extracellular inflammatory
signals and converts them to Snail1 stabilization, which leads
to the acquisition of CSC-like traits, invasion and therapeutic
resistance in BLBC (Fig. 8c).
Second, our study indicates that Dub3 can block the activity of
b-TRCP1 and FBXL14 to stabilize Snail1. Three E3 ligases have
been identified that mediate Snail1 degradation. We previously
demonstrated that GSK-3b phosphorylates Snail1 and promotes
its nuclear export and interaction with b-TRCP1 (ref. 11).
FBXL14, the human homologue of the Partner of Paired
(Ppa) gene product which degrades Snail1 in Xenopus laevis,
also degrades Snail1 in a phosphorylation-independent manner18.
Recently, it has been shown that Snail1 can also be degraded
by FBXO11 in a PDK1 phosphorylation-dependent manner in
the nucleus17,58. It is likely that these different F-box containing
E3 ligases function differently under diverse cellular contexts.
We found that Dub3 can counteract the function of b-TRCP1
and FBXL14 by stabilizing Snail1. Intriguingly, both
b-TRCP1 and FBXL14 can also modulate the degradation of
other EMT-TFs, such Slug and Twist18,59,60. Whether Dub3 can
also counteract the function of b-TRCP1 and FBXL14 in
stabilizing Slug and Twist is a question that requires further
investigation.
Third, our study indicates that Dub3 is an excellent therapeutic
target for the inhibition of breast cancer metastasis and
recurrence. Snail1 becomes stabilized and elevated in BLBC,
but there is no clear ligand-binding domain for targeting Snail1,
which creates a formidable obstacle for the development of
small molecules to inhibit Snail1’s functions. Our results indicate
that Dub3 is a crucial molecule controlling inflammation-
mediated Snail1 stabilization. Indeed, WP1130, which can bind
to the catalytic entry site of the Dub3 UCH domain, blocked
tumour cell migration, invasion and suppressed CSC-like
properties. These data provide a proof-of-concept for therapeutic
development of small molecules to inhibit the activity of Dub3 in
metastatic breast cancer. Consistent with our findings, DUBs
have emerged as a potential therapeutic target, given their role
in several human diseases including cancer61. For example,
the efficacy of a small molecule inhibitor of USP7 in multiple
myeloma disease models provide the rationale for the
development of next-generation USP-based therapies, and
specifically demonstrates the promise of therapeutics targeting
DUB to improve patient outcome62. Previously, Dub3 has
been demonstrated to regulate both cell proliferation and
G1/S cell-cycle progression and is increased in tumours. The
current data strengthens the view that Dub3 is an ideal candidate
for the development of potential inhibitors for cancer treatment
based on the dual role of Dub3 in regulating cell growth
and metastasis.
Methods
Plasmids and reagents. Plasmids of wild-type and deletion mutants for Snail1
were generated as described26. The WT-Dub3 was from addgene. Dub3 (C89S) was
generated using the QuikChange Mutagenesis kit (Stratagene, La Jolla, CA) as
described previously31. All sequences were verified by DNA sequencing. Deletion
mutants of Dub3 were constructed as described previously31. Antibodies used
include: anti-Flag (F3165, 1:4,000, anti-Actin (A2228, 1:10,000), anti-Myc
(9E10, 1:3,000) from Sigma-Aldrich (St. Louis, MO), Anti-Dub3 (Abcam, ab12991,
1:1,000); anti-Ub (Millipore, MAB1510, 1:500), N-cadherin (Upstate, 05-915,
1:1,000), anti-Snail1 (Cell Signaling, 4719, 1:1,000), Vimentin (Ab-2, 1:2,000)
and ERa (Ab-15, 1:1,000) from Neomarkers, anti-HA (Roche, 3F10, 1:10,000),
and anti-E-cadherin (610181, 1:10,000, BD Bioscience) and Claudin-7
(Abcam, ab27487, 1:1,000). Dub3 shRNA expression plasmids were purchased from
MISSION shRNA at Sigma-Aldrich (St. Louis, MO). WP1130 and PR619 were from
Selleck. Smartpool siRNA against human Dub3 was from Dharmacon (Chicago, IL).
Cell culture. The human embryonic kidney HEK293, breast cancer MDA-MB231,
MDA-MB157, MCF7, SKBR3, and colon cancer HCT116, HT-29 cell lines were
purchased from the American Type Culture Collection (Manassas, VA) and grown
in Dulbecco’s modified Eagle’s/F12 medium plus 10% fetal bovine serum as
described previously26. Breast cancer cell lines (T47D, ZR75, BT474) and prostate
cancer cell lines (LNCaP, Du145, PC3) were grown in RPMI1640 plus 10% FBS.
The culture medium for SUM159 and SUM149 is Ham’s F-12 (Invitrogen)
supplemented with 5% FBS, 5 mgml 1 insulin, and 1 mgml 1 hydrocortisone
(Sigma, St. Louis, MO). All the cells lines are routinely checked for morphological
and growth changes to probe for cross-contaminated, or genetically drifted cells.
If any of these features occur, we use the short tandem repeat (STR) profiling
service by ATCC to re-authenticate the cell lines.
Small interfering RNA library screening. The human deubiquitinating enzyme
siGENOME RTF Library was purchased from Dharmacon (Chicago, IL). The
screen was performed according to manufacturer’s instructions. In brief, the cells
were added to the rehydrated Dharmacon RTF siRNA library plates. Two days
later, the cell lysates were extracted and the expression of Snail1 was detected with
western blot.
Invasion assay. Invasion assays were performed in Boyden chambers coated with
Matrigel as instructed by the manufacturer (BD Biosciences, San Jose, CA). Various
cancer cell lines were seeded on the top of the Matrigel in the upper chamber while
the bottom chambers were filled with non-serum culture medium plus 100 nM
LPA. The invasive cancer cells were stained with crystal violent. All experiments
were performed in triplicate.
Single-cell migration assay. Cells were seeded on glass-bottomed dishes
(MatTek, Ashland, MA, USA) that had been coated with 5 mgml 1 fibronectin.
Real-time images were taken under Nikon Biostation IMQ Cell every 10min
for 6 h. The movement of individual cells was analysed using NIS-Element
AR Software (Nikon), and the distance that was travelled during time was
measured as indicated.
GST pull-down assay. Glutathione-S-transferase proteins were expressed as
described previously31. Cells were subjected to lysis in GST pull-down buffer
(20mM Tris, 150mM NaCl and 1% Nonidet P-40 with protease cocktail) and
rotated with glutathione–Sepharose-bound GST-Snail1 or GST-Dub3. The
binding complexes were eluted with SDS–PAGE sample buffer. About one-tenth of
these eluents were analysed by western blot and the rest were examined for the
presence of purified GST protein by Coomassie Blue staining.
Immunoprecipitation and western blotting. For protein extraction, 5 105 cells
per well were plated onto six-well plates and transiently transfected with indicated
expression plasmids. At 48 h after transfection, cells were incubated with or
without the proteasome inhibitor MG132 (10 mM) for an additional 6 h before
protein extraction and western blot analysis. Primary antibodies against Flag
(M2, 1:1,000) and HA (3F10, 1:4,000) were used for protein detection. For
IP, HEK293 cells transfected with the indicated expression plasmids were lysed in
buffer (50mM Tris (pH 7.5), 150mM NaCl, 5 mgml 1 aprotinin, 1 mgml 1
pepstatin, 1% Nonidet P-40, 1mM EDTA and 0.25% deoxycholate). Total cell
lysates (1,000 ml) were incubated overnight with 1 mg of anti-HA or anti-Flag
antibody conjugated to agarose beads (Roche Molecular Biochemicals) at 4 C.
The beads were then washed with lysis buffer, and the immunoprecipitated
protein complexes were resolved by 10% SDS–PAGE. Some important original
immunoblotting results are shown in Supplementary Fig. 9.
Immunofluorescence staining. For IF microscopy, cells were grown on cover
slips, fixed with 4% paraformaldehyde and incubated overnight with anti-Dub3
and anti-Snail1 antibodies. Proteins were visualized by incubation with goat
anti-mouse conjugated with Alexa fluor 568 and goat-anti-rabbit conjugated with
Alexa fluor 488, respectively (Invitrogen, Carlsbad, CA). Finally, cover slips were
incubated with 40 ,60-diamidino-2-phenylindole (Sigma-Aldrich) for 20min and
visualized under a fluorescent microscope.
Immunohistochemical staining. Breast cancer tissue microarray (TMA) of
334 cases of invasive ductal carcinomas is obtained from the tissue bank at the
Markey Cancer Center’s tissue repository at our institute. Tissue samples were
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stained with anti-Dub3 (Abcam, ab12991, 1:100 dilution) and anti-Snail1
(Abcam, ab53519, 1:250 dilution) antibodies, and each sample was scored by an
H-score method that combines the values of immunoreaction intensity and the
percentage of tumour cell staining as described previously19. Chi-square analysis
was used to analyse the relationship between Dub3 and Snail1 expression; statistical
significance was defined as Po0.05.
Quantitative real-time PCR. Total RNA was isolated using RNeasy Mini kit
(Qiagen) according to the manufacturer’s instructions. Specific quantitative
real-time PCR experiments were performed using SYBR Green Power Master Mix
following manufacturer’s protocol (Applied Biosystems).
Fluorescence-activated cell sorting. Cells were detached from plates and incu-
bated with anti-human CD44 and anti-human CD24 (PE-conjugated, ebioscience)
or anti-human CD49f (PE/Cy7 CD49f, e-Bioscience), finally analysed using a
FACSCalibur flow cytometer.
Tumorsphere formation assay. Tumorsphere cultures were performed as descri-
bed in Dontu et al.63. In brief, Cell monolayers were plated as single-cell suspensions
on ultra-low attachment plates (Corning) in DMEM/F12 medium supplemented
with 20ngml 1 EGF, 10mgml 1 insulin, 0.5mgml 1 hydrocortisone and B27.
Tumorspheres were counted via visual inspection after 5–10 days.
In vivo ubiquitination assay. HEK293 cells were transfected with HA-ubiquitin,
Flag-Snail1 and Myc-Dub3 plasmids as indicated. The cells were treated for
6 h with 10mM MG132 at 48 h post transfection, and then lysed. The samples were
immunoprecipitated using anti-Flag agarose (Sigma).
In vitro deubiquitination assay. The in vitro deubiquitination was performed as
described32. Briefly, HA-ubiquitin and Flag-Snail1 were co-expressed in HEK293
cells. After cells were treated with 10 mM MG132 for 6 h, ubiquitinated Snail1 was
isolated by IP with Flag antibody. In a parallel experiment, Myc-Dub3 (WT or CS)
or vector was expressed in HEK293 cells, and purified by IP with anti-Myc Affinity
Matrix (Roche, USA). The purified Dub3 was eluded with Myc peptide, dialyzed
and subsequently incubated with ubiquitinated Snail1 in a deubiquitination
reaction buffer (50mM HEPES, pH 7.5, 100mM NaCl, 5% glycerol, 5mM MgCl2,
1mM ATP and 1mM DTT) at 30 C. The ubiquitinated status of Snail1 was
analysed by western blot with HA antibody.
Complex model structure of Dub3 and WP1130. For protein–ligand docking
studies, the three-dimensional (3D) structure of Dub3-UHC was built by com-
parative protein structure modelling from the homologous USP2 crystal structure
(PDB access code 2HD5) as a template using the programme MODELLER64. The
WP1130 atomic coordinates were generated using the stereochemistry information
stored in PubChem. The complex structure was modelled using the SwissDock
protein-small molecule docking simulation software65. This software adopts the
CHARMM simulation programme66, which preforms numerous conformational
and path sampling methods, free energy estimates, molecular minimization,
dynamics and analysis techniques. This programme has been known to be highly
successful for small and relatively rigid ligands with o10 flexible rotatable bonds.
Fluorescence based thermal shift assay. Purified recombinant Dub3 protein was
used to screen small molecule compounds in a fluorescence based thermal shift
assay49. Dub3 protein was dispersed in a buffer containing 20mM HEPES,
pH 7.0 and 150mM NaCl. The final protein concentration in a 20 ml
reaction volume was 10 mM. Ligands to be tested were added at 2 , 4 , or
6 concentration such that the DMSO concentration never exceeded 2%. SYPRO
Orange dye (Invitrogen) was added last at a 5 concentration. The PCR tubes
were then sealed, centrifuged and heated from 25 to 95 at a rate of 1 per min on
7500 Real-Time PCR machine (Applied Biosystems). Raw data analysis and curve
fitting to calculate Tm values was performed as described.
In vivo tumorigenesis assay. Female SCID mice (6–8 week old) were purchased
from Taconic (Germantown, NY) and maintained and treated under specific
pathogen-free conditions. All procedures were approved by the Institutional
Animal Care and Use Committee at the University of Kentucky College of
Medicine and conform to the legal mandates and federal guidelines for the care and
maintenance of laboratory animals. Mice were injected with the breast cancer
MDA-MB231-luc cells and corresponding stable clones with knockdown of Dub3
or Snail1 expression (5 105 cells per mouse, 6 mice per group) via tail vein
injection. Lung metastasis was monitored by the IVIS bioluminescence imaging
system.
For the spontaneous metastatic model, mice were injected with the breast
cancer MDA-MB231-luc cells and corresponding inducible stable cells via
mammary gland fat pad. The growth of the primary tumour was monitored by
external caliper measurement once a week. When tumours were B1 cm3, the
primary tumour was surgically removed and the incision was closed with wound
clips. The mice were randomly separated into two groups and treated with or
without doxycycline in the drinking water. Animals were euthanized 5 weeks after
primary tumour removal to investigate the development of pulmonary metastasis.
For animals subjected to drug treatment, MDA-MB231-luc cells were injected
into the mammary gland fat pad of 8-week-old female SCID mice. Tumour growth
was monitored with caliper measurements. When tumours were B100mm3 in
size, WP1130 was administered every other day for 2 weeks. Data were analysed
using the Student’s t-test; a P valueo0.05 was considered significant.
Patient samples. The frozen fresh tumour samples were collected from resected
breast tumours from patients at our institute with the approval of the Institutional
Review Board. These frozen samples were ‘snap-frozen’ in liquid nitrogen and stored
at  80 C. Each sample was examined histologically with hematoxylin and eosin
(H&E) stained sections. Regions from tumour samples were microdissected and
examined. Only samples with a consistent tumour cell content of more than 75% in
tissues were used for analysis. Samples were then homogenized using 20 strokes of a
Dounce homogenizer in 1ml of homogenizing buffer. Following centrifugation,
pellets were re-suspended in lysis buffer and processed for western blot.
Data availability. The data that support the findings of this study are available
from the corresponding authors upon reasonable request.
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